Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias. 1997

T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
Institute of Experimental Medicine and Connective Tissue Research, University of Erlangen-Nürnberg, Germany.

Little is known about matrix biochemistry and cell differentiation patterns in chondrogenic neoplasms. This is the first description of the focal expression of collagen type X by neoplastic chondrocytes in situ and its incorporation into the extracellular matrix of cartilaginous tumors. This shows that neoplastic chondrocytes have the potential to undergo the full program of cell differentiation, including hypertrophy, comparable to their physiological counterparts in the growth plate. However, only in benign osteochondromas was a zonal expression of type X collagen found similar to that observed in the growth plate, where the cells immediately above the ossification frontier are selectively positive for type X collagen. In enchondromas and chondrosarcomas, the expression was randomly distributed within the tumors. Surprisingly, in less differentiated chondrosarcomas with spindle-shaped cells and non-cartilaginous extracellular matrix, exceptional expression of collagen type X was observed, which indicates potential uncoupling of collagen type X expression from the differentiated chondrocytic phenotype in neoplastic chondrocytes in vivo.

UI MeSH Term Description Entries
D006984 Hypertrophy General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). Hypertrophies
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009418 S100 Proteins A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif (EF HAND MOTIFS) found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100% saturated ammonium sulfate solution. Antigen S 100,Nerve Tissue Protein S 100,S100 Protein,S-100 Protein,S100 Protein Family,Protein, S100,S 100 Protein
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002812 Chondroma A benign neoplasm derived from mesodermal cells that form cartilage. It may remain within the substance of a cartilage or bone (true chondroma or enchondroma) or may develop on the surface of a cartilage (ecchondroma or ecchondrosis). (Dorland, 27th ed; Stedman, 25th ed) Enchondroma,Chondromas,Enchondromas
D002813 Chondrosarcoma A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed) Chondrosarcomas
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015831 Osteochondroma A cartilage-capped benign tumor that often appears as a stalk on the surface of bone. It is probably a developmental malformation rather than a true neoplasm and is usually found in the metaphysis of the distal femur, proximal tibia, or proximal humerus. Osteochondroma is the most common of benign bone tumors. Chondrosteoma,Exostosis, Cartilaginous,Exostosis, Osteocartilaginous,Cartilaginous Exostoses,Cartilaginous Exostosis,Chondrosteomas,Exostoses, Cartilaginous,Exostoses, Osteocartilaginous,Osteocartilaginous Exostoses,Osteocartilaginous Exostosis,Osteochondromas

Related Publications

T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
January 2024, American journal of cancer research,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
February 2016, Cytotherapy,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
January 1989, Connective tissue research,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
May 1992, Bone and mineral,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
April 1985, The Biochemical journal,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
January 1988, Pathology and immunopathology research,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
December 2007, Journal of biomedical materials research. Part A,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
July 2005, The Journal of biological chemistry,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
January 2016, PeerJ,
T Aigner, and S Frischholz, and S Dertinger, and F Beier, and I Girkontaité, and K von der Mark
January 1990, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!